|1.||Vivier, Eric: 3 articles (06/2015 - 07/2009)|
|2.||Mariuzza, Roy A: 2 articles (06/2015 - 04/2011)|
|3.||Li, Yili: 2 articles (06/2015 - 04/2011)|
|4.||Moretta, Alessandro: 2 articles (06/2011 - 07/2009)|
|5.||Wu, M-R: 1 article (08/2015)|
|6.||DeMars, L R: 1 article (08/2015)|
|7.||Zhang, T: 1 article (08/2015)|
|8.||Sentman, C L: 1 article (08/2015)|
|9.||Xu, Xiaoping: 1 article (06/2015)|
|10.||Gauthier, Laurent: 1 article (06/2015)|
08/01/2015 - "In this study, B7H6, a ligand for the NK cell activating receptor NKp30, was targeted to create a CAR that targets multiple tumor types. "
07/01/2014 - "In this study, we report a novel mechanism of immune escape involving tumor cell shedding of B7-H6, a ligand for the activating receptor NKp30 that mediates NK-cell binding and NK-cell-mediated killing. "
06/01/2015 - "In humans, the activating natural cytotoxicity receptor NKp30 plays a major role in NK cell-mediated tumor cell lysis. "
06/01/2015 - "Expression, crystallization and X-ray diffraction analysis of a complex between B7-H6, a tumor cell ligand for the natural cytotoxicity receptor NKp30, and an inhibitory antibody."
07/01/2014 - "Metalloprotease-mediated tumor cell shedding of B7-H6, the ligand of the natural killer cell-activating receptor NKp30."
04/01/2014 - "In humans, B7-H6 has been shown to facilitate the elimination of lymphoma cells through the interaction with its receptor NKp30. "
09/01/2012 - "Adoptive transfer of T cells expressing a chimeric NKp30 receptor containing a CD28-signaling domain inhibited the growth of a B7-H6-expressing murine lymphoma (RMA/B7-H6) in vivo. "
|3.||HIV Infections (HIV Infection)
|5.||Hepatocellular Carcinoma (Hepatoma)